Effects of monthly ranibizumab injections on visual acuity in patients with neovascular age-related macular degeneration and refractory intraretinal or subretinal fluid.
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2015
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 17 Nov 2015 New trial record